LAVA Therapeutics (LVTX)
(Delayed Data from NSDQ)
$2.64 USD
-0.10 (-3.65%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $2.69 +0.05 (1.89%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth D Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
06/13/2024
Time: -- |
3/2024 | $-0.25 | 0.00% |
Earnings Summary
For their last quarter, LAVA Therapeutics (LVTX) reported earnings of -$0.24 per share, missing the Zacks Consensus Estimate of $0.16 per share. This reflects a negative earnings surprise of 250.00%. Look out for LVTX's next earnings release expected on June 13, 2024. For the next earning release, we expect the company to report earnings of -$0.25 per share, reflecting a year-over-year increase of 52.83%.
Earnings History
Price & Consensus
Zacks News for LVTX
LAVA Therapeutics N.V. (LVTX) Reports Q2 Loss, Tops Revenue Estimates
LVTX: What are Zacks experts saying now?
Zacks Private Portfolio Services